ProSpective MultIcenter ObservationaL Study on the Quality of Life of mCRC RAS Wild-type Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line of Treatment (20140383)First published 11/02/2022 Last updated 02/04/2024 EU PAS number: EUPAS44300StudyFinalised